Caricamento...
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
The pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has led to an extraordinary threat to the global healthcare system. This infection disease, named COVID-19, is characterized by a wide clinical spectrum, ranging from asymptomatic or mild upper respiratory tract...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8172170/ https://ncbi.nlm.nih.gov/pubmed/34093569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.670955 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|